CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities
Net loss	$ (1,911,262)	$ (1,805,687)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	13,425	12,754
Amortization of debt discounts	49,624	196,797
Bad debt expense	5,801
Stock option employee compensation expense	593,073	665,410
Cost of repricing warrants to induce exercise		70,491
Stock issued for interest	4,440
Changes in assets and liabilities:
Accounts receivable	(445,369)	24,537
Inventories	(150,946)	(16,744)
Prepaid expenses and other current assets	22,379	7,427
Other assets
Accounts payable	232,165	(76,063)
Accrual for severance agreement	(42,230)
Accrued expenses	58,765	(22,113)
Net cash used in operating activities	(1,570,135)	(943,191)
Cash flows from Investing Activities
Purchases of equipment	(43,465)	(2,185)
Net cash (used in) investing activities	(43,465)	(2,185)
Cash flows from Financing Activities
Proceeds from sale of stock through private placements	175,000	128,000
Proceeds from sale of stock under stock purchase agreement	480,000	720,003
Proceeds from sale of stock and warrants	100,000
Proceeds from exercise of warrants	25,000	870,000
Proceeds from exercise of stock options	18,200
Repayments of convertible notes with related parties	(85,880)
Payments on related party notes		(33,339)
Proceeds from convertible notes with third parties		175,000
Repayments of convertible notes with third parties	(115,822)
Proceeds from convertible notes with related parties	1,000,000
Payments on Insurance Finance Contract	(16,052)	(10,638)
Net cash provided by financing activities	1,580,446	1,849,026
Net increase in cash and cash equivalents	(33,154)	903,650
Cash and cash equivalents - beginning	90,275	84,194
Cash and cash equivalents - ending	57,121	987,844
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	425	296
Cash paid for income taxes
Supplementary Disclosure of Non-cash Investing and Financing Activities:
Financing of prepaid insurance contracts	16,340	12,774
Beneficial conversion feature of convertible notes	311,949	166,709
Conversion of notes for common stock	82,132	332,996
Loan discount from issuance of warrants	601,949
Common stock issued for interest	$ 4,440